Trial Profile
A Phase II/III Trial on Rizatriptan for Vestibular Migraine
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Rizatriptan (Primary)
- Indications Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- 19 Jan 2021 Status changed from recruiting to completed.
- 07 Oct 2019 Planned End Date changed from 1 Jun 2019 to 1 Jun 2020.
- 07 Oct 2019 Planned primary completion date changed from 1 Oct 2015 to 31 May 2020.